Castration Resistant Prostatic Neoplasms Recruiting Phase 2 Trials for Abiraterone (DB05812)

Back to Castration Resistant Prostatic Neoplasms

Also known as: Prostate Neoplasms, Castration-resistant / Castration-Resistant Prostatic Neoplasms / Prostatic Neoplasms, Castration-Resistant

IndicationStatusPhase
DBCOND0129140 (Castration Resistant Prostatic Neoplasms)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05393791Phase II Randomised Controlled Trial of Patient-specific Adaptive vs. Continuous Abiraterone or eNZalutamide in mCRPCTreatment